NEWMarkets

Avalo Therapeutics (AVTX) CFO Sells $270K in Company Stock

Published on 4/3/2026

#AVTX#insider trading#stock sales#executive compensation
Avalo Therapeutics (AVTX) CFO Sells $270K in Company Stock

AI Summary

Avalo Therapeutics (AVTX) CFO Sullivan sold $270,000 worth of company stock. This transaction may indicate confidence levels from executives regarding the company's future performance. Insider selling can lead to market volatility and may signal potential weaknesses. Understanding these sales is crucial for investors to gauge the sentiment around AVTX.

Source: Read original article (opens in new tab)

Related News

Ensysce Biosciences (ENSC) Director Resigns From Board
Markets

Ensysce Biosciences (ENSC) Director Resigns From Board

Apr 3

Photronics (PLAB) SVP Wang Hsueh-Chun Sells $420,831 in Stock
Markets

Photronics (PLAB) SVP Wang Hsueh-Chun Sells $420,831 in Stock

Apr 3

Twin Vee PowerCats (VEEE) Receives Nasdaq Delisting Notice for Price
Markets

Twin Vee PowerCats (VEEE) Receives Nasdaq Delisting Notice for Price

Apr 3

United Airlines (UAL) Raises Checked Bag Fees by $10-50 Due to Fuel Costs
Markets

United Airlines (UAL) Raises Checked Bag Fees by $10-50 Due to Fuel Costs

Apr 3